A strong second half has brought trading for the full year in line with expectations and leaves the business well set for 2019. An exciting pipeline of new products should supplement an already strong organic growth outlook and could lead to material upgrades in time. We see a clear path for management to realise its ambition of building a £100m+ business over the next 3-5 years. This note looks in detail on how this can be achieved.
14 Jan 2019
Clear route to £100m+
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Clear route to £100m+
Surgical Innovations Group plc (SUN:LON) | 0.5 0 0.0% | Mkt Cap: 4.66m
- Published:
14 Jan 2019 -
Author:
Chris Glasper -
Pages:
3
A strong second half has brought trading for the full year in line with expectations and leaves the business well set for 2019. An exciting pipeline of new products should supplement an already strong organic growth outlook and could lead to material upgrades in time. We see a clear path for management to realise its ambition of building a £100m+ business over the next 3-5 years. This note looks in detail on how this can be achieved.